Cancer BiologyNeuro-OncologyPeer-reviewed
High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in SHH-medulloblastoma
Leilei Zhou, Niek F. H. N. van Bree, Lola Boutin…·Margareta Wilhelm
7 citations